RxDoctor Payments Data

Samir Saba

Clinical Cardiac Electrophysiology · Pittsburgh, PANPI 1811962269

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (39.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Boston Scientific at 45.2% of the total. 2025 is the largest year on record at $18,435, more than ten times the $1,209 reported in 2019.

$55,350in general payments, 2019–2025

Across 124 payments — averaging $446.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$25K
  • Medtronic$20K
  • Abbott$10K
  • Biosense Webster, Inc.$103
  • GE HealthCare$60
  • Impulse Dynamics (USA) Inc.$39
  • plus $64 from 2 others
$1,400,231in research payments, 2019–2025

Across 128 payments — averaging $10,939 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$1.3M
  • Boston Scientific$49K
  • Medtronic$15K

What the payments were for

  • Consulting fees$22,08840%
  • Speaking & faculty fees$13,36924%
  • Grants$1470%
  • Travel & lodging$15,05127%
  • Food & beverage$4,6818%
  • Education$140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$55,350 in reported general payments places this provider in the 75th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$60,912
Medicare patients
163
Services billed
446

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban363$400,747
XareltoRivaroxaban25$37,234
EntrestoSacubitril/Valsartan19$34,371
Cardizem CdDiltiazem Hcl13$33,884
Dofetilide27$10,437
Diltiazem 24hr Er (Cd)Diltiazem Hcl90$4,355
Metoprolol Succinate116$2,948
Amiodarone Hcl98$1,905
SotalolSotalol Hcl87$1,809
Flecainide Acetate31$952
Metoprolol Tartrate51$544
Carvedilol21$323
Lisinopril21$313
Spironolactone13$269
Atenolol20$260

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →